C haracterization of ion channels of immune cells other than dendritic cells (DCs)
4 revealed the essential role of transmembrane ion fluxes in various functions of the immune system (1) . These electrically nonexcitable cells have been shown to possess both voltage-dependent and second messengergated ion channels that are crucial for their activation, proliferation, and migration (1) . Voltage-gated K ϩ channels (VGPCs) have been described as the predominant ion channels controlling the resting membrane potential and tuning intracellular Ca 2ϩ signaling in lymphocytes, monocytes, macrophages, and mouse DCs (1) (2) (3) (4) . The dynamic changes in the expression of ion channels, including that of VGPCs upon various extracellular (EC) stimuli, are essential for the activation and terminal differentiation of immune cells, and thus may modulate specific immune responses (5) . The biophysical characteristics of VGPCs are modified by the presence of auxiliary subunits, which provide with an additional mechanism for fine-tuning K ϩ currents to the ever changing conditions (6) . Among VGPCs, a member of the Shaker family, the Kv1.3 channel is extensively studied for its potential role in lymphocyte and macrophage activation. Kv1.3 channels are almost exclusively expressed in the immune system, and the blockade of these channels is associated with selective inhibition of T cell activation and proliferation (for review, see Refs. 4 and 7). Inwardly rectifying K ϩ channels (K ir 2.1), Ca 2ϩ -activated K ϩ channels (IKCa1 or K Ca 3.1), and Kv1.5/Kv1.3 heterotetramer channels have also been described in T cells and in cells of the mononuclear phagocytic system (3, 4, (7) (8) (9) . These channels, along with Kv1.3, maintain a hyperpolarized membrane potential, which enhances and sustains the Ca 2ϩ signal upon activation. The intracellular Ca 2ϩ signal is also influenced by the presence of Ca 2ϩ release-activated Ca 2ϩ channels in lymphocytes, macrophages, and DCs. These channels are responsible for the sustained Ca 2ϩ signal required for the expression of numerous functionally important genes, such as the IL-2 gene (10) .
Changes in the expression of ion channels accompanying terminal differentiation of myeloid cells directed our attention toward DCs, the most potent professional APCs. DCs localized to peripheral tissues act as molecular sensors of microenvironmental changes such as stress, inflammation, or pathogenic invasion. They possess a high capacity to acquire exogenous soluble or particulate substances, which involve self and foreign proteins, various metabolites, apoptotic and damaged cells, or other particles. Tissue DCs are poor APCs, and require danger signals to get activated and acquire high T cell priming and activating potential. Danger signals for DCs include mediators exposed by inflamed or damaged tissues, the feedback signals released by the activated DCs themselves or by other constitutive or induced signals (11) . The phenotypic characteristics and physiological functions of these cells change dramatically during the maturation and activation process, making DCs capable of inducing either T cell immunity or tolerance.
Human monocyte-derived DCs provide with a good tool for studying the phenotypic and functional properties of immature, tissue-resident and mature, T cell stimulatory myeloid DCs. The objective of this study was to compare the expression and functional activity of voltage-gated ion channels in DCs generated in vitro from human peripheral blood monocytes. We studied the biophysical and pharmacological characteristics of the currents expressed by immature and mature monocyte-derived DCs, and by the means of PCR-based cloning we identified the ion channels being responsible for the measured currents. We report in this study for the first time that immature DCs (IDCs) express voltagegated sodium channels (VGSCs) of type Nav1.7. The transition from the immature to the mature DCs (MDCs) induced by an inflammatory mixture results in dramatic changes in the expression of voltage-gated ion channels. The expression of Nav1.7 is downregulated within 24 h after stimulation, whereas morphological and phenotypic changes associated with the development into MDCs are accompanied by the up-regulation of Kv1.3 K ϩ channels, consistent with previously reported studies on other immune cells (1) (2) (3) (4) . We propose that the switch of ion channel expression during monocyte-derived DC maturation may support the distinct functional activities of these cells associated with their different maturation states.
Materials and Methods

Dendritic cells
Human myeloid DCs were generated from blood monocytes isolated from buffy coats by Ficoll-Pacque (Amersham Biosciences) gradient centrifugation (12) . Monocytes were separated by positive selection with anti-CD14-coated magnetic beads (Miltenyi Biotec) from PBMC. Purified monocytes (Ն95%) were plated at 2 ϫ 10 6 cell/ml concentration and cultured in serum-free AIMV medium (Invitrogen) in the presence of 100 ng/ml IL-4 and 75 ng/ml GM-CSF (PeproTech) given on days 0 and 2. Activation of IDCs was induced by an inflammatory mixture containing 10 ng/ml TNF-␣, 5 ng/ml IL-1␤, 20 ng/ml IL-6, 75 ng/ml GM-CSF (PeproTech), and 1 g/ml PGE 2 (Sigma-Aldrich). MDCs were identified by flow cytometry using anti-CD83 mAb (Immunotech), as described elsewhere (13) .
Protein extracts and Western blotting
Cells were washed twice in cold PBS and lysed on ice with lysis solution (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 (pH 7.4)) supplemented with 2 M pepstatin A, 2 M leupeptin, 2 g/ml aprotinin, and 1 mM PMSF as protease inhibitors. Cell lysates were centrifuged at 10,000 ϫ g for 10 min at 4°C, and the protein content of the supernatant was determined using Bradford protein assay. Samples were separated into aliquots and stored at Ϫ80°C. Protein samples (50 g) were boiled in Laemmli SDS loading buffer and separated on 10% SDS-PAGE. Other details of the Western blotting were as described elsewhere (14) using Abs against Kv1.5 (1/500; Alomone Labs). As a loading and transfer control, an anti-␤-actin mAb (1/5000; Sigma-Aldrich) was used. The specificity of the Kv1.5 Ab was tested with a control Ag peptide provided by the manufacturer. Raw 264.7 macrophages and HEK-293 cells were grown, and HEK-293 cells were transienltly transfected with Kv1.5 cDNA, as described elsewhere (14) . Samples were analyzed 24 h after transfection.
Electrophysiology
Patch clamping. Standard whole-cell patch-clamp techniques were used, as described previously (15) . Whole-cell measurements were conducted using Axopatch-200 and Axopatch-200A amplifiers connected to personal computers using Axon Instruments Digidata 1200 data acquisition boards (Molecular Devices). For data acquisition and analysis, the pClamp8 software package (Molecular Devices) was used. Pipettes were pulled from GC 150 F-15 borosilicate glass capillaries (Clark Biomedical Instruments) in five stages and fire polished to gain electrodes of 2-3 M⍀ resistance in the bath. Series resistance compensation up to 85% was used to minimize voltage errors and achieve good voltage clamp conditions (V err Ͻ 5 mV). Solutions. The normal bath or EC solution was as follows (in mM): 145 NaCl, 5 KCl, 1 MgCl 2 , 2.5 CaCl 2 , 5.5 glucose, and 10 HEPES (pH 7.35, 305 mOsm/kg). A total of 145 mM choline-Cl substituted for NaCl in the choline-EC bath solution (pH 7.35, 305 mOsm/kg). NaCl was replaced by equimolar tetraethylammonium (TEA) chloride in the 10 mM TEA-EC solution. The composition of the pipette solution for current recording in MDCs was as follows (in mM): 140 KF, 11 K 2 EGTA, 1 CaCl 2 , 2 MgCl 2 , and 10 HEPES (pH 7.20, ϳ295 mOsm/kg). This pipette solution was supplemented with 5 mM NaCl for recording currents in IDCs. Test substances. Toxins (tetrodotoxin (TTX); charybdotoxin (ChTx); margatoxin (MgTx)) were dissolved in the standard EC bath solution supplemented with 0.1 mg/ml BSA (Sigma-Aldrich) to suppress nonspecific binding of the toxins to the wall of the tubes and to the petri dish. Bath perfusion around the measured cell with different test solutions was achieved using a gravity-flow perfusion setup with eight input lines and PE10 polyethylene tube output tip having flanged aperture to reduce the turbulence of the flow. Excess fluid was removed continuously.
Electrophysiological protocols and data analysis
Inactivation kinetics of the Na ϩ and the K ϩ current. Cells were depolarized to evoke whole-cell currents, and the decaying parts of current traces were fitted using a single-exponential function, as follows:
in,x ϩ I SS (1) where I i is the amplitude of the decaying current component, in,x is the inactivation time constant for either the Na ϩ ( in,Na ) or the K ϩ ( in,K ) current, and I ss is the steady-state value of the current at the end of depolarizing pulse. Current-voltage relationship for Na ϩ current. To study the voltage dependence of steady-state activation of the Na ϩ conductance, a family of 40-ms-long depolarizing test pulses ranging from Ϫ50 mV to ϩ100 mV was applied every 15 s. A P/5 online leak subtraction protocol was used to minimize capacitance artifacts. The peak currents were determined, plotted as a function of test potential, and fitted using the following equation:
where G is the whole-cell peak Na ϩ conductance and E rev is the reversal potential for Na ϩ ions. The free parameters of the last term of the equation, V m,a and s a , are the midpoint and the slope factor of the voltage dependence of steady-state activation, respectively. Current-voltage relationships were individually fitted for each cell, and the free parameters (G, E rev , V m,a , and s a ) were averaged to obtain the characteristic values. Steady-state inactivation of Na ϩ current. To elucidate the voltage dependence of steady-state inactivation of the Na ϩ current in IDCs, 5-s-long prepulse potentials (V p ) ranging between Ϫ120 and 0 mV were applied, followed by a test potential to 0 mV for 20 ms. The inward peak currents were normalized to the maximal peak currents recorded at V p ϭ Ϫ120 mV to express the fraction of channels that were not inactivated by the prepulse (I norm (V p )). I norm (V p ) was plotted as a function of the prepulse potential for each cell separately, and the Boltzmann function was fit to each data series, with values V m,i and s i corresponding to the midpoint and the slope factor of the voltage dependence of steady-state inactivation, respectively, as follows:
V m,i and s i obtained for individual cells were averaged to report the characteristic values. Recovery from inactivation of Na ϩ currents. A conventional two-pulse protocol was used to determine the kinetics of recovery from inactivation of Na ϩ channels at a hyperpolarized potential. A pair of depolarizing pulses from Ϫ120 to 0 mV for 50 ms was delivered separated by the interpulse interval (IPI). IPI was varied between 1 and 20 ms, and the membrane potential was held at Ϫ120 mV during IPI. The degree of recovery from inactivated state at a given IPI was characterized by the recovered fraction (RF) of the Na ϩ current: RF ϭ (P 2 Ϫ I ss1 )/(P 1 Ϫ I ss1 ), where P 1 and P 2 denote the peak currents obtained during the first and the second depolarizing pulses, respectively, and I ss1 represents the current at the end of the first depolarizing pulse. RF was plotted as a function of IPI, and a single exponential rising function was fitted to the data, resulting in the time constant for recovery from inactivation ( r ), as follows:
The r was determined separately for each cell and averaged to give the characteristic value reported.
Voltage dependence of steady-state activation of K ϩ current in MDCs. MDCs were held at Ϫ120 mV and depolarized to the test potentials ranging from Ϫ70 mV to ϩ60 mV for 800 ms every 90 s. Peak whole-cell conductance (G(V)) at each test potential was calculated from the peak current (I p ) at test potential V and the K ϩ reversal potential (E r ) using G(V) ϭ I p /(V Ϫ E r ). G(V) values were normalized to the maximal K ϩ conductance of the cell; the resulting G(V) norm data were plotted as a function of test potential. Data points were fitted using the Boltzmann function to obtain the midpoint (V 1/2 ) and the slope (k) of the voltage dependence of steadystate activation, as follows:
V 1/2 and k were determined separately for each cell and averaged to give the characteristic values reported. Dose-response curves. The extent of current inhibition by various inhibitors was defined by the remaining current fraction (RCF), which is calculated as I/I 0 , where I and I 0 are the peak currents in the presence and absence of a blocker (e.g., TTX), respectively. RCF values obtained at different toxin concentrations were plotted, and the Hill equation assuming 1:1 channel-toxin stoichiometry was fitted to the data points to obtain the equilibrium dissociation constant (K d ), as follows:
where [T] is the concentration of the toxin applied. Where indicated, K d was estimated from RCF obtained at a single toxin concentration using Equation 6 .
Cloning and sequencing
To prepare cDNA for cloning of Na ϩ channels, monocyte-derived IDCs or MDCs were collected on days 5 and 6, respectively, and total RNA was isolated with TRI Reagent (Sigma-Aldrich). Reverse transcription was performed at 42°C for 60 min from 500 ng of total RNA using Superscript II reverse transcriptase (Promega). The DNA, encoding a conserved region of the Na ϩ channels, was amplified from cDNA with PCR, using high fidelity Pfu polimerase (Promega) and degenerate primers, as follows: 5Ј-GATT TCCAGGGAGATAAGACAAGCAG-3Ј and 5Ј-GAAGCAGAGGCTGA ACCTATGAATT-3Ј. Specific PCR products were gel purified, ligated into the pCRBlunt vector (Invitrogen), and transformed into the Escherichia coli strain TOP10 by the standard heat shock method. Plasmid DNAs obtained from 20 single bacterial colonies were first analyzed by restriction digestion. Inserts of five randomly picked clones were fully sequenced on an ABI Prism 310 Automatic Sequencer (Applied Biosystems). All five selected constructs carried the same insert.
Real-time quantitative RT-PCR
To quantify the expression of voltage-gated ion channel genes, we applied the TaqMan PCR system using the 5700 Sequence Detector (Applied Biosystems). Gene-specific TaqMan PCR assays for human Kv1.3 and Kv1.5 (14) and Nav1.7 channels were purchased from Applied Biosystems, whereby each probe was synthesized with a fluorescent 5Ј-reporter dye (FAM) and a 3Ј-quencher dye (TAMRA). Parallel TaqMan PCR assays for each gene target were performed with cDNA samples. To quantify the relative expression of voltage-gated channel expression, 8 ng of reversetranscribed RNA was used in a 25-l reaction volume. As an internal control, 36B4 was used. The PCR was performed at 94°C, 1 min, followed by 40 cycles at 94°C, 12 s, and 60°C, 1 min. The PCR product was analyzed on a real-time PCR cycler (SDS 5700; Applied Biosystems). The relative amounts of individual channel transcripts are given in relation to those of 36B4. A "no-reverse transcriptase control" with untranscribed RNA and a "no-template control" with water were performed parallel in all experiments. Each series of experiments was performed in triplicates. The relative expression of the target gene was calculated using the comparative method (2 Ϫ⌬⌬Ct ) (16).
Results
TTX-sensitive Na ϩ current in IDCs
Fig . 1A shows whole-cell currents measured in a single IDC in response to a voltage ramp from Ϫ100 mV to ϩ50 mV. The record shows the activation of a marked inward current at membrane potentials more depolarized than Ϫ30 mV. This inward current is voltage gated and potentially can be attributed to the influx of either Na ϩ or Ca 2ϩ ions or even both. To clarify the nature of the charge carrier, ion substitution experiments were performed by changing the normal EC bath solution for Na ϩ -free choline EC solution. As shown in Fig. 1B , the robust inward current recorded at 0 mV test potential in the Na ϩ -containing solution completely disappears in the Na ϩ -free choline-based solution. The loss of the Na ϩ current in choline-EC solution was quickly reversed by perfusing the bath with normal EC bath solution (Fig. 1B, dashed line). The inset shows that the peak current was reduced to ϳ0 pA between two consecutive pulses upon changing to choline-EC and recovered to the control value upon changing to normal EC bath with a similar rate, i.e., between two consecutive pulses. These experiments demonstrated that the decrease of the inward current is due to the replacement of Na ϩ with the impermeable monovalent choline ion, and thus, strongly argue for the presence of Na ϩ channels in the membrane of IDCs. The peak Na ϩ current density at 0 mV test potential was quite variable, ranging between Ϫ15.1 pA/pF and Ϫ110 pA/pF with median and mean current densities of Ϫ56.8 pA/pF and Ϫ61.9 Ϯ 7.3 pA/pF (n ϭ 20), respectively.
To characterize the Na ϩ current in IDCs, we used TTX, a ubiquitous inhibitor of voltage-gated Na ϩ channels. Fig. 1C shows typical current traces recorded in the absence and in the presence of 100 nM TTX. The effect of the toxin was rapid and reversible; the peak current was reduced to ϳ37% of the control upon perfusion with TTX-containing normal EC bath, and recovered to the control value within a few pulses following a switch to the toxinfree normal EC bath (see inset). The effect of TTX was concentration dependent, and the dose-response data were fit with the Hill equation (Equation 6), resulting in a K d value of 55 nM (Fig. 1D) . These results revealed that the inward current detected in IDCs is mediated by TTX-sensitive voltage-gated Na ϩ channels.
Biophysical characterization of the Na ϩ current in IDCs
To further characterize the Na ϩ channel expressed in IDCs, we determined the biophysical characteristics (equilibrium and kinetic properties) of the whole-cell Na ϩ current gating. In general, VGSCs are closed at hyperpolarized potentials, open quickly upon depolarization, and then get inactivated. Recovery from the inactivated state into the closed state takes place at negative membrane potentials and is necessary for repopulating the closed, activable channel pool. Thus, we used the simplest model that was proposed and worked out by Hodgkin and Huxley in 1952 (17) as a working hypothesis of our additional experiments. Fig. 2A shows a family of currents recorded by depolarizing an IDC from the holding potential of Ϫ120 mV to various test potentials (for additional details, see the figure legend and Materials and Methods). The peak current at each test potential was determined and plotted as a function of the test potential in Fig. 2B . The peak current-voltage relationship shows that the activation threshold of the current is approximately Ϫ50 mV, and the current reverses close to ϩ60 mV. The current-voltage relationship is nonlinear at depolarized test potentials; thus, Equation 2 was used to characterize the voltage dependence of steady-state activation of the Na ϩ channels. The superimposed solid line in Fig. 2B displays the best fit of Equation 2 to the data points. This cell is characterized by a peak whole-cell Na ϩ conductance (G) of 3.5 nS, and a reversal potential (E rev ) of ϩ62.6 mV for the Na ϩ current. Parameters describing the voltage dependence of steady-state activation, i.e., the test potential at which 50% of the Na ϩ channels are activated (midpoint, V m,a ) and the slope of voltage-dependent gating (s a ), were Ϫ24.8 and 9.1 mV, respectively. Characteristic values for the parameters of The voltage dependence of steady-state inactivation was studied using the pulse protocol shown in Fig. 2C . The cell was held at different prepulse potentials (V p ) for 5 s and then depolarized to 0 mV to evoke whole-cell Na ϩ currents with magnitudes proportional to the fraction of Na ϩ channels not inactivated by the preceding prepulse. The resulting family of current records is shown in Fig. 2C . The peak currents normalized to the maximal values were plotted vs V p cell by cell, and the Boltzmann function (Equation 3) was fitted to the data points. The characteristic values of the voltage dependence of steady-state inactivation, i.e., the membrane potential at which 50% of the channels are inactivated was V m,i ϭ Ϫ87.6 Ϯ 3.3 mV (n ϭ 3), and the slope was s i ϭ Ϫ5.1 Ϯ 0.1 mV (n ϭ 3). The voltage dependence of steady-state inactivation is represented in Fig. 2D as the average of the fraction of noninactivated channels at different prepulse potentials for n ϭ 3 independent experiments along with the best fit Boltzmann function. Fig. 3 represents the kinetic features of the Na ϩ current. As shown in Figs. 1 and 2 , the Na ϩ current activates and inactivates quickly upon the depolarization of the membrane. The inactivation kinetics of the current was characterized by the inactivation time constant ( i,Na ). i,Na was determined by fitting a single exponential function (Equation 1) to the decaying part of the currents (see Materials and Methods). The dash-dot lines superimposed over the Na ϩ currents in Fig. 3A indicate the best fits to Equation 1 at four test potentials. The voltage dependence of i,Na is shown in Fig.  3B , which indicates that inactivation kinetics of the current is getting faster with increasing depolarizations. A, Voltage dependence of Na ϩ current activation. The 50-ms-long depolarizing step pulses ranging from Ϫ50 mV to ϩ100 mV were applied to the cells every 15 s in 10-mV increments from the holding potential of Ϫ120 mV (pulse protocol is shown on the top; P/5 online leak subtraction was applied). Twenty-ms-long segments of the current traces evoked by depolarizations between Ϫ50 mV and ϩ50 mV and to ϩ100 mV are shown for clarity of the figure and for the emphasis of the fast kinetics. B, Voltage dependence of Na ϩ current activation. Peak whole-cell current (•) at each test potential was determined from the currents shown in A. The superimposed solid line shows the best fit of Equation 2 to the data points with G ϭ 3.5 nS, E rev ϭ 62.6 mV, V m,a ϭ Ϫ24.8 mV, and s a ϭ 9.1 mV. C, Voltage dependence of steady-state inactivation of the Na ϩ current. The cell was held for 5 s at various prepulse potentials (V p ) ranging between Ϫ120 and 0 mV, and then depolarized to 0 mV (Test pulse) for 20 ms (pulse protocol is shown on the top). Prepulse/Test pulse sequences were separated by 15 s at the holding potential of Ϫ120 mV. The gradual loss of the current with depolarizing prepulses (indicated with arrows) demonstrates steady-state inactivation of Na ϩ channels. D, The inward peak currents recorded following prepulse potential V p were normalized to the maximal peak current recorded following a Ϫ120 mV prepulse potential to express the fraction of channels that were not inactivated by the prepulse (I norm (V p )). The fraction of noninactivated channels was averaged and plotted as a function of the prepulse potential (n ϭ 3). The superimposed solid line is the best fit of the Boltzmann function (Equation 3) to the data points with V m,i ϭ Ϫ88.0 mV and s i ϭ Ϫ5.9 mV. Error bars indicate SEM.
Following a full inactivation of the current, the membrane has to be hyperpolarized to allow recovery of the channels from inactivation. The kinetics of recovery from inactivation was studied using a conventional two-pulse protocol (see Materials and Methods) in which the time between two consecutive depolarizing pulses (IPI) is gradually increased, thereby resulting in larger and larger currents during the second pulse (Fig. 3C) . The RF of the current as a function IPI was plotted for individual cells, and a single exponential function was fitted to the individual datasets (Equation 4; see Materials and Methods), resulting in the time constant for recovery from inactivation of r ϭ 4.9 Ϯ 0.9 ms (n ϭ 3). The kinetics of recovery from inactivation is represented in Fig.  3D as the average of the RF at different IPIs for n ϭ 3 independent experiments along with the best fit of Equation 4 to the data points.
These results show that IDCs express TTX-sensitive rapidly inactivating Na ϩ channels. Depolarizations up to ϩ100 mV and 50 ms in duration failed to elicit any other type of inward or outward current under our experimental conditions (n Ͼ 20).
Outward K ϩ current in MDCs
The activation of IDCs by an inflammatory cytokine mixture (see Materials and Methods) induced a dramatic change in the electrophysiological properties of the cells. The voltage-ramp experiment in Fig. 4A indicates that the inward current characteristic of IDCs disappeared in MDCs; furthermore, a voltage-gated outward current is activated at membrane potentials more depolarized than Ϫ30 mV. A similar approach, used for the biophysical characterization of the Na ϩ channels, was applied to specify the type(s) of channels generating the outward current, including the determination of the Data points are given as the average of four independent measurements. Please note the logarithmic scaling of the ordinate. Error bars indicate SEM. C, Representative whole-cell current traces used to characterize the time course of the recovery from inactivation of the Na ϩ current in an IDC. Pairs of depolarizing step pulses from Ϫ120 to 0 mV for 50 ms were separated by IPI ranging from 1 to 20 ms. The membrane potential was set to Ϫ120 mV during the IPI. D, RF of the Na ϩ current was calculated as (P 2 Ϫ I ss1 )/(P 1 Ϫ I ss1 ), where P 1 and P 2 denote the peak currents obtained at the first and the second pulses, respectively, and I ss1 represents the steady-state current at the end of the first depolarizing pulse. RF at each IPI was calculated and averaged for n ϭ 3 independent experiments and plotted as a function of IPI. A single exponential rising function (Equation 4) was fitted to the data points to result in 4.76 s for the time constant of recovery from inactivation ( r ). Equation 4 was also fitted to RF-IPI relationships obtained for individual cells, and the resulting r was 4.9 Ϯ 0.9 ms (n ϭ 3). Error bars indicate SEM. current-voltage relationship, the voltage dependence of steadystate activation, the inactivation kinetics, and the pharmacological properties of the current. Fig. 4B illustrates a series of current traces evoked by 800-mslong step depolarization pulses to different test potentials from a holding potential of Ϫ120 mV in every 90 s. The records show that the activation threshold of the current is between Ϫ40 and Ϫ30 mV; the current quickly activates and almost completely inactivates with a relatively slow kinetics. The leak-corrected peak current at each test potential was determined and plotted as a function of the test potential in the inset of Fig. 4B . This I p -V relationship shows that extrapolated reversal potential of the current is more negative than Ϫ60 mV, and that the voltage dependence of the activation of the channels is very steep above Ϫ40 mV. Based on these characteristics, the expression of voltage-gated K ϩ channels is predicted in MDCs. The peak K ϩ current density at ϩ50 mV test potential varied between 6.7 pA/pF and 111.9 pA/pF with median and mean current densities of 38.6 pA/pF and 48.1 Ϯ 9.4 pA/pF (n ϭ 13), respectively.
The I p -V relationships were used to calculate the K ϩ conductance of the membrane at each test potential, and the normalized conductance-test potential (G norm -V) relationships were generated for each cell individually, as detailed in Materials and Methods, and the Boltzmann function (Equation 5) was fitted to the data points. The fits resulted in Ϫ25.0 Ϯ 0.8 mV for the midpoint and 5.2 Ϯ 0.4 mV for the slope of the voltage dependence of steadystate activation (n ϭ 4). The G norm -V relationships are represented in Fig. 4C as the average of the G norm at different test potentials for n ϭ 4 independent experiments along with the best fit of the Boltzmann function (Equation 5 ) to the data points. Fig. 4B shows that the whole-cell K ϩ current in MDCs displays inactivation. The superimposed dashed lines in Fig. 4B indicate the best fit single exponential functions (Equation 1) to the decaying part of the current traces. The resulting time constants ( i,K ) were used to characterize inactivation kinetics of the K ϩ current. i,K at ϩ50 mV was 127.4 Ϯ 9 ms (n ϭ 3); the inactivation kinetics showed negligible voltage dependence at membrane potentials more positive than Ϫ10 mV (Fig. 4D) .
The biophysical characteristics of the current, especially the inactivation kinetics, narrow significantly the range of ion channels suitable to produce the whole-cell currents in MDCs. Based on these and the predominant expression of Kv1.3 channels in various cell types of the immune system, we hypothesized that Kv1.3 channels may be expressed in MDCs. To test this hypothesis, we applied peptide and nonpeptide ion channel blockers.
Pharmacological characterization of the outward K ϩ current
Kv1.3 channels inactivate by the slow (P/C-type) inactivation mechanism that is characterized by the ability of extracellularly applied TEA to inhibit the current and to slow the inactivation process simultaneously by the foot-in-the-door mechanism (18) . This feature is demonstrated in Fig. 5 for the whole-cell K ϩ current recorded in MDCs. The figure shows that the amplitude of the whole-cell K ϩ current is reduced to ϳ55% of the control in the presence of 10 mM TEA; the single-point estimate of the equilibrium dissociation constant from Equation 6 is 12.4 Ϯ 0.7 mM (n ϭ 3; see Materials and Methods). The figure also demonstrates that the inactivation kinetics of the current is slower in the presence of TEA; the time constants were 189 ms for control and 282 ms in the presence of 10 mM TEA.
Two peptide toxins with different affinities and selectivities for Kv1.3, ChTx, and MgTx were used in subsequent pharmacological experiments. Fig. 6A shows typical current traces recorded in the absence and in the presence of 2 nM ChTx. The effect of the toxin was reversible; the peak current was reduced to ϳ50% of the control upon perfusion with ChTx-containing normal EC bath and recovered to the control value following a switch to the toxin-free normal EC bath (washout). ChTx reduced the K ϩ current in a dose-dependent manner (Fig. 6B) . The Hill equation (Equation 6) was fit to the dose-response data, resulting in an equilibrium dissociation constant of 3.4 nM (Fig. 6B) . The inhibition of the whole-cell K ϩ current by MgTx, a Kv1.3-specific toxin, is shown in Fig. 6C . The trace recorded 300 s after the start of the perfusion with toxin-containing (50 pM) EC solution indicates the equilibrium block of the current by MgTx. The dose response of the current inhibition by MgTx is shown in Fig. 6D . Fitting the Hill equation to the data points resulted in an equilibrium dissociation constant of 39.8 pM, which is characteristic of the inhibition of Kv1.3 channels. The washout of the toxin was extremely slow, requiring 20 -30 min for significant recovery from block (data not shown).
Based on the biophysical and pharmacological data, we propose that the channel responsible for the outward K ϩ currents in MDCs is Kv1.3.
Identification of the electrophysically characterized voltage-gated Na ϩ channel of IDCs
A PCR-based strategy was used to identify the TTX-sensitive VGSC responsible for the Na ϩ current detected in the membrane of IDCs. Before this study, no Na ϩ channel-related DNA sequences of DCs were known; thus, we probed a cDNA library using degenerate primers based on a conserved sequence common to all VGSCs. Using these degenerate primers, a 387-bp portion of the gene was amplified, cloned, and sequenced, as described in Materials and Methods. The nucleotide sequence of 5 of 20 cloned constructs fitted perfectly to the human gene SCN9A (GenBank accession number NM_002977; http://www.ncbi.nlm.nih.gov/ GenBank/), which encodes for the voltage-gated Na ϩ channel 1.7 ␣ subunit. Sequences corresponding to Nav channels other than Nav1.7 were not found in either of the clones. These findings indicate that the molecular identity of the channels responsible for the inward Na ϩ currents in of IDCs is Nav1.7.
Expression of mRNAs for voltage-gated ion channels in differentiating monocyte-derived DCs
To quantify the relative expression of the identified voltage-gated ion channels, we measured mRNA expression levels by real-time RT-PCR in IDCs and MDCs activated by an inflammatory mixture. Because several cell types of myeloid origin also express Kv1.5 channel subunits, the mRNA expression level for Kv1.5 was also determined along with that of the Nav1.7 and the Kv1.3 channel. To compare the relative expression of these mRNA transcripts in IDCs and MDCs, the data were normalized to the expression of the housekeeping gene 36B4. In line with the results of the biophysical characterization, the expression of Nav1.7 mRNA was the highest in IDCs, whereas the MDCs expressed Kv1.3 transcripts (Fig. 7, A and B) . As compared with IDCs, the changes of the relative expression of Nav1.7 and Kv1.3 in MDCs were 118-fold decrease and 38-fold increase, respectively, calculated using the comparative method (2 Ϫ⌬⌬Ct ). These data demonstrate the coordinated, but opposing regulation of well-defined Nav1.7 and Kv1.3 channels in differentiating monocyte-derived DCs. Fig. 7C shows that Kv1.5 mRNA transcripts were also isolated from both IDCs and MDCs, however, at a lower level, with no significant change in the expression during differentiation. The presence of Kv1.5 mRNA and the functional absence of Kv1.5 subunits in the current records indicated Western blot experiments to assess the expression of this subunit in DCs of various differentiation states. Fig. 7D shows that the expression of the Kv1.5 subunit relative to that of ␤-actin is similar in both IDCs and MDCs. HEK-293 cells transfected with Kv1.5 and Raw 264.7 macrophages, endogenously expressing the Kv1.5 subunit (14) , were used to demonstrate the sensitivity of the assay. In addition, similar to Kv1.5 gene expression, the relative ␤-actin abundance and the fact that the same amount of protein was evaluated in each lane (group) indicate that the protein expression of Kv1.5 is much lower in either IDCs or MDCs than in Raw 264.7 macrophages.
Discussion
Differentiation and maturation of DCs from monocytes are linked to marked phenotypic, gene expression, and functional changes (19) . The major function of IDCs is to internalize exogenous soluble and particulate tissue components and collect stimuli associated with environmental changes for delivering this molecular information to lymph node T lymphocytes. Mobilization and maturation of DCs to highly efficient APCs with the unique capability to prime Ag-specific T lymphocytes in peripheral lymphoid organs require inflammatory and danger signals. Activation-induced changes of DCs include the down-regulation of some endocytic/phagocytic receptors; up-regulation of specific sets of chemokine receptors, adhesion, and costimulatory molecules; changes in morphology, cytoskeleton, and mobility; and reorganization of the endolysosomal and MHC class II-rich intracellular compartments (20) . In this study, we describe a dramatic change in the plasma membrane expression of two specific ion channels, i.e., Nav1.7 and Kv1.3, in the course of monocyte-derived DC maturation. For the first time in the literature, we demonstrated the presence and activity of voltage-gated Na ϩ channels in the plasma membrane of IDCs. The identification of the channel being responsible for the whole-cell current required both electrophysiological and molecular biological approach. Using PCR-based cloning, we identified the Na ϩ channels expressed in IDCs as Nav1.7 encoded by the SCN9A gene, and the cloned sequence did not match the sequence of any other VGSC. The Nav1.7 channel is classified as TTX sensitive; it is inhibited by nanomolar concentrations of TTX (21) . Our results are consistent with this; however, the affinity of the channels for TTX is somewhat lower (K d ϭ 55 nM) than reported by Klugbauer et al. (21) for human Nav1.7 expressed in oocytes (K d ϭ 25 nM) and much lower than for rat Nav1.7 (K d ϭ 4 nM) (22) . Although we do not know the explanation for these differences, it must be noted that the affinities of toxins for ion channels obtained in different expression systems vary significantly (23) .
Regarding the biophysical parameters of gating, the previously published values for the voltage dependence of steady-state activation of Nav1.7 are between Ϫ20 and Ϫ25 mV for the V m,a , regardless of the expression system used (21, 22, 24 -26) , and our results in IDCs are compatible with those (V m,a ϭ Ϫ19.8 Ϯ 3.0 mV). Fast inactivation kinetics of Nav1.7 is characterized by time constants in the order of 1 ms at voltages in which the current is maximal (Ϫ10 to 0 mV) (25) ; however, biphasic current decay has also been reported (26) . This fast inactivation kinetics has only been achieved by coexpressing the Nav1.7 subunits with the auxiliary ␤ 1 subunit, which accelerates the inactivation kinetics as much as 10-fold (24) . The fast inactivation kinetics reported in this study (0.70 Ϯ 0.09 ms at Ϫ10 mV at maximal inward current; Figs. 2 and 3) indicate that Nav1.7 might be in complex with a ␤ 1 subunit in IDCs; furthermore, the small size of IDCs allows better voltage-clamp conditions as compared with oocytes, thereby resulting in apparently faster kinetics. The midpoint for the voltage dependence of steady-state inactivation (V m,i ) obtained in this study is slightly more negative than reported by Cummins et al. (25) (Ϫ73.6 mV), but significantly more negative than Ϫ60.5 mV reported by Klugbauer et al. (21) for the human Nav1.7 expressed in HEK cells in both studies. In the latter study, KCl was used in the pipette-filling solution, whereas in our study and in Cummins et al. (25) F Ϫ was used as the major anion and F Ϫ is known to shift the voltage dependence of steady-state inactivation of Nav1.9 channels in the hyperpolarizing direction (27) . Other factors explaining the discrepancies might be the difference in V m,i obtained in various expression system (21, 24) and native cells (26) , and the difference in the pulse protocols and holding potentials applied in various studies. In summary, apart from slight differences, the biophysical and pharmacological properties of Nav1.7 currents recorded in IDCs agree well with those reported for Nav1.7 in other preparations.
The ␣ subunits of the Nav1.7 channel are expressed in the dorsal root ganglion neurons, sympathetic neurons, Schwann cells, and neuroendocrine cells (28) . Their physiological functions include action potential initiation and transmission in peripheral neurons in response to nociceptive stimuli. These channels are mainly responsible for mechanosensation and for the development of inflammatory pain (29) . IDCs reside primarily within or beneath of epithelial surfaces such as the skin, bronchial, and gastrointestinal mucosal layers (30) , and are also concentrated at peripheral nerve endings and endoneurium, which may suggest a possible relationship between nociceptive stimuli and DC functions (31, 32) .
The presence of voltage-gated Na ϩ channels has been previously confirmed in cells derived from precursors of the myeloid lineage. TTX-sensitive Nav1.6 channels were studied in brain macrophages (microglias), where the inhibition of these channels with TTX significantly reduced the phagocytic activity of these cells and led to the improvement of neuroinflammatory diseases (33) . In another study, intracellular localization of Nav1.5 (TTXinsensitive) and Nav1.6 channels was described in human monocyte-derived macrophages, with no detectable cell surface expression of either of these channels (34). Nav1.5 was shown to localize in the late endosome, and TTX inhibited the phagocytosis and certain endosomal functions in this cell type. Although monocytederived DCs, microglia, and macrophages all originate from a common myeloid precursor, these data suggest that different VGSC and specific localization of these channels are required for their dedicated functions.
We also demonstrated that IDCs challenged by inflammatory stimuli changed the cell surface expression of ion channels, and thus, the MDCs are characterized by another set of specific channels. Real-time RT-PCR demonstrated the expression of transcripts for Kv1.3 and Kv1.5 in MDCs. This raises the possibility that a mixture of Kv1.3 and Kv1.5 homotetramers and Kv1.3/ Kv1.5 heterotetramers might be responsible for the whole-cell currents observed in MDCs, similarly to bone marrow-derived macrophages (14, 35) and MDCs of the CNS (36) . Based on the following considerations, we argue that Kv1.3 determines the properties of the whole-cell currents in our study: 1) The wholecell current displays single-exponential inactivation kinetics with a time constant of ϳ127 ms at ϩ50 mV (Fig. 4, B and D) , which is characteristic of Kv1.3 (37). Kv1.5 homotetrameric channels, on the contrary, have very slow and biphasic inactivation kinetics with time constants of ϳ450 ms and 5 s (38). Kv1.3/Kv1.5 heterotetramers should have intermediate inactivation kinetics depending on the subunit stoichiometry and calculated from the cooperative interaction between subunits (37). Thus, the whole-cell current carried by five different species of channels (homotetrameric Kv1.3 and Kv1.5 and three types of heterotetramers) should have complex decay kinetics with slow components in it (37), which was clearly not the case for whole-cell currents in MDCs. 2) Homotetrameric Kv1.5 channels are ϳ30-fold less sensitive to TEA than Kv1.3 homotetramers (39) . As all four subunits contribute equally to the TEA binding site (40) Kv1.3/Kv1.5 heterotetramers should have lower affinity for TEA than Kv1.3 homotetramers. Again, our results show the contrary, i.e., ϳ50% of the whole-cell current is inhibited by 10 mM TEA (Fig. 5) , which is characteristic of Kv1.3 channels. 3) Kv1.5 channels are resistant to inhibition by scorpion toxins used in this study (ChTx, MgTx) (38) . Kv1.3/Kv1.5 heterotetramers are less sensitive to MgTx inhibition, depending on the subunit stoichiometry 3-to 100-fold decrease in the affinity was reported by Felipe and colleagues (14, 35) . Thus, a significant proportion of Kv1.5 homo-or heterotetramers would result in a residual toxin-insensitive current even at a high toxin concentration, which otherwise blocks almost completely Kv1.3 channels. In contrast, we measured higher than 90% blockage of the whole-cell current at 50 nM ChTx concentration (Fig. 6B ) and a full block at 500 pM MgTx concentration (Fig.  6D ). 4) The presence of the mixture of homo-and heterotetrameric channels would result in a significant deviation of the dose-response relationship from a model (Equation 6 ), in which a single species of channels interacts with a single inhibitory peptide. On the contrary, our dose-response relationships showed K d values of 3.4 and 39.8 nM, for ChTx and MgTx, respectively, which values are characteristic for inhibition of Kv1.3 (39) , and Equation 6 fits perfectly to the dose-response relationships (Fig. 6, B and D) , thereby arguing against the existence of Kv1.5 homotetramers and Kv1.3/Kv1.5 heterotetramers in MDCs. In conclusion, although mRNA specific for Kv1.5 can be found in both IDCs and MDCs and Western blot analysis confirmed the expression of Kv1.5 subunits in these cells, the protein expression level is too small to affect the properties of whole-cell current.
We can exclude the contribution of IKCa1 channels (the Ca 2ϩ -activated K ϩ channel, which is expressed in many lymphoid cells) to the whole-cell current by the lack of the elevated cytosolic free Ca 2ϩ concentration required for the activation of these channels (i.e., the pipette-filling solution contined 11 mM EGTA and 140 mM F Ϫ ) (9) . Based on these arguments, we conclude that Kv1.3 channels are responsible for the whole-cell outward current in MDCs, and the properties of the current agree with those reported in the literature for Kv1.3 in human T cells (41) . Kv1.3 is involved in the regulation of membrane potential and Ca 2ϩ signaling in lymphocytes, macrophages, and monocytes (1, 42, 43) . The expression of Kv1.3 channels is important in the activation of macrophages, where their blockade inhibits the secretion of TNF-␣ and IL-8 cytokines (43). Brain macrophages express another type of voltage-gated channel, the Kv1.5, which was proven not to be functional in bone marrowderived macrophages (3) . A recent study, however, proposed that the K ϩ currents seen in bone marrow-derived macrophages are due to the expression of three voltage-gated channels: Kv1.3, Kv1.5, and Kv1.3/Kv1.5 heteromeric channels (14, 35) . The oligomeric composition of functional VGPCs could have a crucial effect on intracellular signaling events, determining the macrophage-specific response upon different physiological stimuli (14) . The presence of an outward rectifying K ϩ conductance was described in DCs isolated from murine spleen (2), but the ion channel responsible for that current was not identified. The expression Ca 2ϩ -activated K ϩ channels of IKCa1 type were described in the KG-1 erythroleukemia cell line that possesses numerous characteristics of human DCs (44) . A recent study showed the existence of Kv1.3-like and Kv1.5 currents in MDCs of the CNS (36) . The lack of a Kv1.5 current in monocyte-derived MDCs and its presence in MDCs in the CNS raise the question as to whether Kv1.5 expression could be linked to a special function and distribution of these latter cells.
Although significant efforts have been made to demonstrate the inhibition of different functions of IDCs (pinocytosis and phagocytosis) and MDCs (cytokine release and T cell proliferation) by TTX and MgTx, respectively, we failed to inhibit any of these functions by the toxins (data not shown). These negative results, however, do not exclude the biological role of the channels described in this study. For example, currently unknown factors in the culture medium might mask the biological effects, but not the inhibition of the currents. A similar phenomenon was described earlier, in which the inhibition of proliferation of T lymphocytes by ChTx could only be demonstrated in serum-free medium, but not in a culture medium containing human AB serum (45) . A detailed analysis of the components revealed that the presence of IL-2 in the culture medium can overcome the antiproliferative effects of ChTx in cultured T cells.
In this study, we demonstrate that the inflammation-induced maturation of monocyte-derived DCs is accompanied by a substantial change in the cell surface expression of VGSCs. Such alterations are common in the course of the terminal differentiation of immune cells, and the identification of two DC-related ion channels with restricted expression and linked, but opposing regulation in MDCs may have an impact on the targeted modulation of the cross-talk of immune cells (46) . The Nav1.7 channels described in this study are known to be abundantly expressed in the peripheral nervous system, but their presence in the plasma membrane of IDCs is unique in the immune system. Because VGSCs of nonexcitable immune cells are considered to play a role in phagocytosis and migration, which are principal functions of IDCs, the selective blockade of VGSCs can be a useful tool to modulate MDC functions. The presence of Kv1.3 channels in MDCs is not surprising because Kv1.3 is probably responsible for adjusting membrane potential, and through this may control Ca 2ϩ signaling pathways during the activation of these cells. Further investigation of the specific function of these channels, as well as the regulation of intracellular Ca 2ϩ signaling during the maturation process, may open up new avenues for targeting DC-directed T lymphocyte activation, polarization, and differentiation for immunomodulation.
Our detailed biophysical approach and expression profiling also revealed that these channels exhibit distinct functional activities and are regulated concomitantly during monocyte-derived DC maturation.
